Hungary imposes windfall tax on drug producers - govt decree
BUDAPEST, Dec 24 (Reuters) - Hungary's government
imposed a windfall tax on drug producers which will be based on
their net revenues generated in 2022 and 2023, according to a
decree published late on Friday.
The rate of the tax increases progressively, and will be 8%
on net revenues exceeding 150 billion forints ($398.36 million).
The companies will have to pay the new windfall tax for 2022 and
2023 both next year.
($1 = 376.5400 forints)
(Reporting by Krisztina Than)
((krisztina.than@thomsonreuters.com;))
Recent news on Richter Gedeon Vegyeszeti Gyar Nyrt
See all newsAI in Hungary could unlock productivity gains of €15 billion, McKinsey says
Brief: Hungary's Richter and Hetero announce cooperation for development of semaglutide injection
Brief: Hungary's Richter and Acrux agree to license transdermal Estradiol spray for Australia
Brief: Hungary's Richter Says 2026 Guidance Fully Reiterated High-Single-Digit Growth In Revenues And Clean EBIT (At Constant Exchange Rates)
Brief: Hungary's Richter says European Commission granted approval for Tuyory, its biosimilar to Tocilizumab